Abstract:Eph receptors, the largest subfamily of receptor tyrosine kinases, are linked with proliferative disease, such as cancer, as a result of their deregulated expression or mutation. Unlike other tyrosine kinases that have been clinically targeted, the development of therapeutics against Eph receptors remains at a relatively early stage. The major reason is the limited understanding on the Eph receptor regulatory mechanisms at a molecular level. The complexity in understanding Eph signalling in cells arises due to following reasons: (1) Eph receptors comprise 14 members, two of which are pseudokinases, EphA10 and EphB6, with relatively uncharacterised function; (2) activation of Eph receptors results in dimerisation, oligomerisation and formation of clustered signalling centres at the plasma membrane, which can comprise different combinations of Eph receptors, leading to diverse downstream signalling outputs; (3) the non-catalytic functions of Eph receptors have been overlooked. This review provides a structural perspective of the intricate molecular mechanisms that drive Eph receptor signalling, and investigates the contribution of intra- and inter-molecular interactions between Eph receptors intracellular domains and their major binding partners. We focus on the non-catalytic functions of Eph receptors with relevance to cancer, which are further substantiated by exploring the role of the two pseudokinase Eph receptors, EphA10 and EphB6. Throughout this review, we carefully analyse and reconcile the existing/conflicting data in the field, to allow researchers to further the current understanding of Eph receptor signalling.

Eph Receptor Interclass Cooperation is Required for the Regulation of Cell Proliferation

Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression.

Structures of an Eph receptor tyrosine kinase and its potential activation mechanism.

Eph receptor signalling: from catalytic to non-catalytic functions

Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity

Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands

Co-clustering of EphB6 and ephrinB1 in trans restrains cancer cell invasion

Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding

The Role of the Eph Receptor Family in Tumorigenesis

Determining The Effects Of Ephrin Type-B Receptor 6 And Type-A Receptor 3 On Facilitating Colorectal Epithelial Cell Malignant Transformation

EPHA1 and EPHB4 tyrosine kinase receptors regulate epithelial morphogenesis

Eph receptor and ephrin function in breast, gut, and skin epithelia

Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly

Eph receptor tyrosine kinase and its relation to cancer

Eph Receptors and Ephrins in Tumorigenesis

Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells

Eph Receptors: Actors in Tumor Microenvironment.

Eph Receptors and Ephrins in Cancer: Common Themes and Controversies

Ephrinb1 Is Essential In T-Cell-T-Cell Co-Operation During T-Cell Activation

Contrasting Effects of Cancer-Associated Mutations in EphA3 and EphB2 Kinases

Regulation of signaling interactions and receptor endocytosis in growing blood vessels